A Single-Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Sitagliptin in Adolescents.
Phase of Trial: Phase I
Latest Information Update: 15 May 2017
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- 10 Jun 2017 Biomarkers information updated
- 25 Jun 2013 Secondary results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
- 25 Jun 2013 Primary results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History